Safety data also plays a role in guiding these practices
Brand-name Ozempic without assistance: $17,442 (18 months at $969/month) Brand-name Ozempic with maximum savings card benefit (best-case scenario for commercially insured): $450 (18 months at $25/month assuming you qualify and maintain eligibility) Compounded semaglutide: $3,582 (18 months at $199/month) The cost difference between brand-name without assistance and compounded alternatives is $13,860 over 18 months
Additionally, semaglutide has been shown to promote weight loss, improve blood pressure, and reduce inflammation markers, all of which contribute to its cardioprotective effects
GLP-3 (Reta) is not currently named on the WADA 2026 Prohibited List
Gallbladder and Biliary Tract Diseases In addition to obesity, rapid and excessive weight loss is known to reduce gallbladder motility, alter bile composition, and thereby predispose individuals to gallstone formation